Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Ion Beam Applications SA (IBAB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011164
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solutions, radiopharmacy solutions and particle accelerators. IBA’s products and services find application in the treatment of cancer and neurologic and cardiac disorders. It also provides sterilization and ionization solutions for industrial uses. The company has operational presence in North America, South America, Europe and Asia. IBA is headquartered in Louvain la Neuve, Walloon Brabant, Belgium.

Ion Beam Applications SA (IBAB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ion Beam Applications SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ion Beam Applications SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ion Beam Applications SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ion Beam Applications SA, Medical Equipment, Deal Details 12
Venture Financing 12
HIL Applied Medical Raises Funds in Series C Financing 12
Private Equity 13
CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 13
Argos Soditic Completes Management Buyout Of Cisbio Bioassays For US$32.4 Million 14
SK Capital Partners Acquires 60% Stake In IBA Molecular Imaging From Ion Beam Applications For US$234 Million 16
Partnerships 18
Elekta to Enter into Agreement with IBA 18
Royal Philips, Singapore Institute of Advanced Medicine Forms Joint Venture with Varian Medical Systems and Ion Beam Applications 19
Ion Beam Applications Enters into Agreement with Koninklijke Philips 21
IBA Partners with Philips India 22
Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 23
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 24
Ion Beam Applications Enters into Co-Development Agreement with Mobius Medical Systems 25
RaySearch And Ion Beam Applications Enter Into Agreement To Develop Proton Treatment Planning System 26
IBA Group Enters Into An Agreement With Royal Philips Electronics 27
IBA Dosimetry Enters Into Distribution Agreement With Axios Oncology 28
Acquisition 29
Ion Beam Applications Acquires 25% Stake In PET Net 29
Ion Beam Applications SA – Key Competitors 30
Ion Beam Applications SA – Key Employees 31
Ion Beam Applications SA – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Strategy And Business Planning 34
Sep 25, 2016: IBA and Philips step up collaboration in adaptive proton therapy planning to advance personalized cancer care 34
Financial Announcements 35
Nov 16, 2017: IBA Trading Update – Third Quarter 2017 35
Aug 24, 2017: IBA Reports Half Year Results for 2017 37
May 10, 2017: IBA trading update – first quarter 2017 38
Nov 16, 2016: IBA Trading Update – Third Quarter 2016 39
Aug 25, 2016: IBA Reports Half Year 2016 Results 41
May 11, 2016: IBA Trading Update – First Quarter 2016 42
Feb 17, 2016: IBA announces 2016 guidance and upgrades 2015 expectations 44
Corporate Communications 45
Jun 02, 2016: IBA Strengthens Management Team For Future Growth 45
Government and Public Interest 46
Jun 14, 2016: Proton Therapy Arrives at Miami Cancer Institute 46
Product News 47
02/02/2016: HUPTI Advances Cancer Treatment to Another Level for Cancer Patients With the Addition of Pencil Beam Scanning 47
Other Significant Developments 48
Sep 27, 2016: IBA’s Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated 48
Sep 23, 2016: IBA to open the path towards adaptive proton therapy 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Ion Beam Applications SA, Medical Equipment, Key Facts, 2016 2
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ion Beam Applications SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ion Beam Applications SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ion Beam Applications SA, Deals By Market, 2011 to YTD 2017 9
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
HIL Applied Medical Raises Funds in Series C Financing 12
CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 13
Argos Soditic Completes Management Buyout Of Cisbio Bioassays For US$32.4 Million 14
SK Capital Partners Acquires 60% Stake In IBA Molecular Imaging From Ion Beam Applications For US$234 Million 16
Elekta to Enter into Agreement with IBA 18
Royal Philips, Singapore Institute of Advanced Medicine Forms Joint Venture with Varian Medical Systems and Ion Beam Applications 19
Ion Beam Applications Enters into Agreement with Koninklijke Philips 21
IBA Partners with Philips India 22
Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 23
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 24
Ion Beam Applications Enters into Co-Development Agreement with Mobius Medical Systems 25
RaySearch And Ion Beam Applications Enter Into Agreement To Develop Proton Treatment Planning System 26
IBA Group Enters Into An Agreement With Royal Philips Electronics 27
IBA Dosimetry Enters Into Distribution Agreement With Axios Oncology 28
Ion Beam Applications Acquires 25% Stake In PET Net 29
Ion Beam Applications SA, Key Competitors 30
Ion Beam Applications SA, Key Employees 31
Ion Beam Applications SA, Subsidiaries 32

★海外企業調査レポート[Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務分析
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ziehm Imaging GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that develops, produce and markets mobile X-ray based imaging solutions. The company's products include c-arms with flat panel detectors, c-arms with 3D imaging and c-arms with image intensifier. It offers Ziehm Vision RFD 3D, 3D …
  • Biosearch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biosearch Technologies Inc (Biosearch), a subsidiary of LGC Ltd is a biotechnology company that designs and manufactures regents. The company develops, and manufactures custom oligonucleotide-based tools. Its products include valupanel reagents, fluorogenic probes and primers, stellaries RNA …
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務分析
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …
  • TAG Oil Ltd (TAO):石油・ガス:M&Aディール及び事業提携情報
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas company that explores, develops and produces natural gas and crude oil across Canada. The company owns and operates oil and gas properties in Taranaki Basin and East Coast Basin. It undertakes oil and gas projects such as Boar Hill Frontier, Waitangi H …
  • Kier Group plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Microchip Technology Incorporated (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Incorporated (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …
  • Centrotec Sustainable AG (CEV):企業の財務・戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy company that provides energy saving systems. The company provides products such as medical technology plastics, climate systems, gas flue systems and engineering plastics, among others. It also offers ventilation with heat recovery, heating s …
  • Westar Energy Inc (WR):企業の財務・戦略的SWOT分析
    Westar Energy Inc (WR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Poudre Valley Rural Electric Association Inc:企業の戦略的SWOT分析
    Poudre Valley Rural Electric Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Pacific Energy Ltd (PEA):企業の財務・戦略的SWOT分析
    Summary Pacific Energy Ltd (PEL) operates as a power generation company that develops, operates and maintains renewable energy power stations. The company operates Kalgoorlie Power Systems that operates site locations across Northern Territory, Western Australia and South Australia, among others. It …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Otter Tail Corp (OTTR):企業の財務・戦略的SWOT分析
    Otter Tail Corp (OTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CenturyLink, Inc.:企業の戦略・SWOT・財務情報
    CenturyLink, Inc. - Strategy, SWOT and Corporate Finance Report Summary CenturyLink, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nestle Health Science SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferring Pharmaceuticals Inc (Ferring), a subsidiary of Ferring International Center SA is a biopharmaceutical company that conducts research and development services. The company develops peptide-based drugs and biotechnology derived medicines. It also develops effective and patient-friendly …
  • Meredith Corporation (MDP):企業の財務・戦略的SWOT分析
    Meredith Corporation (MDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆